Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Sherwin

Showing results (91-100 of 105) with videos related to

Pageof 11
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1983
Depression of natural killer cytotoxicity after in vivo administration of recombinant leukocyte interferonA E Maluish, J R Ortaldo, J C Conlon, et al.
JAMA|November 19, 1982
A multiple-dose phase I trial of recombinant leukocyte A interferon in cancer patientsS A Sherwin, J A Knost, S Fein, et al.
Blood|November 1, 1984
Effects of monoclonal antibody therapy in patients with chronic lymphocytic leukemiaK A Foon, R W Schroff, P A Bunn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1988
The determination of an immunologically active dose of interferon-gamma in patients with melanomaA E Maluish, W J Urba, D L Longo, et al.
Molecular Human Reproduction|June 23, 2007
Mifepristone induced progesterone withdrawal reveals novel regulatory pathways in human endometriumR D Catalano, H O Critchley, O Heikinheimo, et al.
The Journal of Clinical Endocrinology and Metabolism|June 1, 2006
Effect of an intrauterine device on the gene expression profile of the endometriumJ A Horcajadas, A M Sharkey, R D Catalano, et al.
The New England Journal of Medicine|July 3, 1986
Local and systemic effects of intradermal recombinant interferon-gamma in patients with lepromatous leprosyC F Nathan, G Kaplan, W R Levis, et al.
The New England Journal of Medicine|November 1, 1984
Treatment of advanced non-Hodgkin's lymphoma with recombinant leukocyte A interferonK A Foon, S A Sherwin, P G Abrams, et al.
Journal for Immunotherapy of Cancer|March 28, 2017
Safety, tumor trafficking and immunogenicity of chimeric antigen receptor (CAR)-T cells specific for TAG-72 in colorectal cancerKristen M Hege, Emily K Bergsland, George A Fisher, et al.
Journal of Clinical Immunology|July 1, 1989
A phase I trial of recombinant human interferon-gamma in patients with Kaposi's sarcoma and the acquired immunodeficiency syndrome (AIDS)H C Lane, R T Davey, S A Sherwin, et al.
Pageof 11

Showing results (91-100 of 105) with videos related to

Sort By:
Pageof 11
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1983
Depression of natural killer cytotoxicity after in vivo administration of recombinant leukocyte interferonA E Maluish, J R Ortaldo, J C Conlon, et al.
JAMA|November 19, 1982
A multiple-dose phase I trial of recombinant leukocyte A interferon in cancer patientsS A Sherwin, J A Knost, S Fein, et al.
Blood|November 1, 1984
Effects of monoclonal antibody therapy in patients with chronic lymphocytic leukemiaK A Foon, R W Schroff, P A Bunn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1988
The determination of an immunologically active dose of interferon-gamma in patients with melanomaA E Maluish, W J Urba, D L Longo, et al.
Molecular Human Reproduction|June 23, 2007
Mifepristone induced progesterone withdrawal reveals novel regulatory pathways in human endometriumR D Catalano, H O Critchley, O Heikinheimo, et al.
The Journal of Clinical Endocrinology and Metabolism|June 1, 2006
Effect of an intrauterine device on the gene expression profile of the endometriumJ A Horcajadas, A M Sharkey, R D Catalano, et al.
The New England Journal of Medicine|July 3, 1986
Local and systemic effects of intradermal recombinant interferon-gamma in patients with lepromatous leprosyC F Nathan, G Kaplan, W R Levis, et al.
The New England Journal of Medicine|November 1, 1984
Treatment of advanced non-Hodgkin's lymphoma with recombinant leukocyte A interferonK A Foon, S A Sherwin, P G Abrams, et al.
Journal for Immunotherapy of Cancer|March 28, 2017
Safety, tumor trafficking and immunogenicity of chimeric antigen receptor (CAR)-T cells specific for TAG-72 in colorectal cancerKristen M Hege, Emily K Bergsland, George A Fisher, et al.
Journal of Clinical Immunology|July 1, 1989
A phase I trial of recombinant human interferon-gamma in patients with Kaposi's sarcoma and the acquired immunodeficiency syndrome (AIDS)H C Lane, R T Davey, S A Sherwin, et al.
Pageof 11